Xavier Duburcq’s Post

View profile for Xavier Duburcq

CEO at ProductLife Group

Today, I am proud to announce that the leading Italian player, Pharma D&S, renowned for its quality and expertise, is part of ProductLife Group.   Founded more than 20 years ago and with almost 250 employees, Pharma D&S Group will reinforce our European Leadership and the value we deliver to the market.  With this merge, we are we are now a 1300 people company spread in over 50 different countries.      A warm welcome to Riccardo Ballerini, Marco Conti, Lino Fabrizi and the entire Pharma D&S, C&P Engineering and Pharma Education Center PEC collaborators! #leadership #PLG #Growth #pharma #quality #regulatorycompliance #engineering #education #21 Invest

Hi Xavier, congratulations for this strategic merger!

Julie Canovas

Freelance booster for the Biotech & Pharmaceutical industries

1y

Félicitations Xavier Duburcq !

Rani Kalla

Global Regulatory Affairs | Leasdership | Team Establishment | RA Outsourcing Project Delivery | Process Transfer | Global LCM | Client Relationship | Product Registraiton Cycle - Emerging Markets

1y

Congratulations and welcome to our new colleagues to PLG family👏

Oliver J. Peters

Executive Placement | Passionate Matchmaker | International Networker | Cross-Industry-Connector | MedTech | Dental | Pharma | Biotech

1y

Well done! Keep pushing!

  • No alternative text description for this image
Claudio Puglisi

Managing Partner at Entourage GmbH - PDA Italy Chapter Board Member

1y

Congrats Xavier!

Yael Mamane

Visionary Market leader with a Master degree in Management & Marketing

1y

Congrats Xavier and all the team You reach your ambitious objectives, well done

Jerome COUPE

Global Head of Scientific Affairs

1y

A great achievement !!

Myriam BEN SAID

Regulatory Affairs Specialist at ProductLife Group

1y

Complimenti 🎉 E benvenuti ai nostri colleghi italiani !

Like
Reply
Khadija NEMRI

Clinical Trials & Regulatory affairs consultant

1y

Congratulations 👏

See more comments

To view or add a comment, sign in

Explore topics